Kappa/lambda serum FLC in patients with IgG4-RD. Comparison of... | Download Scientific Diagram
Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma - Abbi - 2016 - British Journal of Haematology - Wiley Online Library
Case 966-- Clinical Chemistry Case
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
UHL GP NEWS
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
IgG4-related disease: what a hematologist needs to know | Haematologica
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation
Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez
About Multiple Myeloma | UCSF Helen Diller Family Comprehensive Cancer Center
Protein Marker Evaluation of Monoclonal Gammopathies | AACC.org
Full text] Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Types of Multiple Myeloma | International Myeloma Foundation
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
Pseudo-monoclonal gammopathy: a report of four cases